Vilanterol
Vilanterol
Vilanterol (pronounced: vil-an-ter-ol) is a long-acting beta-adrenoceptor agonist (LABA) used in the treatment of chronic obstructive pulmonary disease (COPD) and asthma. It is often used in combination with other medications such as fluticasone furoate and umeclidinium bromide.
Etymology
The term "Vilanterol" is derived from the combination of its chemical structure and its therapeutic role. The prefix "Vil-" is derived from its chemical structure, while "-terol" is a common suffix for drugs that act as receptor agonists.
Usage
Vilanterol is used as a bronchodilator, a type of medication that relaxes and opens the airways to the lungs, making it easier to breathe. It is used in the long-term management of asthma and chronic obstructive pulmonary disease (COPD).
Mechanism of Action
Vilanterol works by stimulating the beta-2 adrenergic receptors in the lungs, which causes the muscles in the airways to relax and widen. This allows more air to flow into and out of the lungs, reducing symptoms such as shortness of breath and wheezing.
Side Effects
Common side effects of Vilanterol may include headache, throat irritation, and upper respiratory tract infection. Serious side effects may include worsening breathing problems, chest pain, fast or irregular heartbeat, and allergic reactions.
Related Terms
External links
- Medical encyclopedia article on Vilanterol
- Wikipedia's article - Vilanterol
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski